Dr. Brij Mohan Makkar: Guest Editor for Feb 2021
With over 77 million Indians living with diabetes and more than 30 billion obese; as well as increased usage of terminologies like “diabesity and...
With over 77 million Indians living with diabetes and more than 30 billion obese; as well as increased usage of terminologies like “diabesity and...
Previous clinical evidence shows the beneficial effect of continuous subcutaneous insulin infusion (CSII) as compared to multiple daily injection (MDI) insulin regimens in patients...
An elevated intrahepatic triglyceride (IHTG) is the classic feature of nonalcoholic fatty liver disease (NAFLD) and can be reduced by weight loss. It is...
The main cause of liver diseases worldwide is metabolic associated fatty liver disease (MAFLD) and affects nearly a quarter of the global population. Mohammed...
Introduction Beta-blockers (β-blockers) are associated with intra-class variability including differences in their pharmacokinetic profile. Determination of intra-class pharmacokinetic as well as pharmacodynamic variability of...